Quest Diagnostics
DGX
$138.79
Share price
-0.46%
Change (1 day)
-4.22%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Market capitalization of Quest Diagnostics (DGX)
Market cap: $15.45 Billion
As of March 2023 Quest Diagnostics has a market cap of $15.45 Billion. This makes Quest Diagnostics the world's 1045th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Quest Diagnostics from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $15.45 B | -13.28% |
| 2022 | $17.81 B | -16.05% |
| 2021 | $21.22 B | 32.15% |
| 2020 | $16.06 B | 13.07% |
| 2019 | $14.20 B | 26.35% |
| 2018 | $11.24 B | -16.26% |
| 2017 | $13.42 B | 5.36% |
| 2016 | $12.74 B | 25.24% |
| 2015 | $10.17 B | 5.35% |
| 2014 | $9.65 B | 25.25% |
| 2013 | $7.70 B | -16.43% |
| 2012 | $9.22 B | 0.73% |
| 2011 | $9.15 B | -0.59% |
| 2010 | $9.21 B | -16.75% |
| 2009 | $11.06 B | 8.99% |
| 2008 | $10.15 B | -1.13% |
| 2007 | $10.27 B | -0.09% |
| 2006 | $10.27 B | 0.62% |
| 2005 | $10.21 B | 5.66% |
| 2004 | $9.66 B | 28.64% |
| 2003 | $7.51 B | 34.85% |
| 2002 | $5.57 B | -19.05% |
| 2001 | $6.88 B |
End of Day market cap according to different sources
On Mar 28th, 2023 the market cap of Quest Diagnostics was reported to be:
$15.80 Billion
$15.45 Billion
$15.40 Billion
$15.45 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $19.53 B | 26.40% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $2.82 B | -81.72% | 🇺🇸 USA |
 Psychemedics PMD | $29.88 M | -99.81% | 🇺🇸 USA |
 NeoGenomics
NEO | $2.18 B | -85.83% | 🇺🇸 USA |
 Qiagen QGEN | $10.41 B | -32.59% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $0.12 B | -99.22% | 🇺🇸 USA |